Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mycodern Spolka Akcyjna Logo
Producer of functional foods and supplements for manufacturing and distribution.
Poland
MCD
MYUNGMOON PHARM CO.,LTD Logo
Develops, manufactures, and commercializes specialized and general medicines.
South Korea
017180
Nanexa AB Logo
Develops long-acting injectables using a proprietary nanotechnology drug delivery system.
Sweden
NANEXA
Nanobiotix Logo
Develops a physics-based, first-in-class radioenhancer for cancer treatment.
France
NANO
Nanobiotix S.A. Logo
A late-stage biotech developing physics-based nanotherapeutics to enhance radiotherapy.
United States of America
NBTX
Nanoform Finland OYJ Logo
Offers nanoparticle engineering services to enhance drug performance for pharma clients.
Finland
NANOFH
NanoRepro AG Logo
Develops, manufactures, and distributes rapid diagnostic tests and food supplements.
Germany
NN6
Nasus Pharma Ltd Logo
Develops powder-based intranasal therapies for acute medical emergencies.
United States of America
NSRX
NATURAL ALTERNATIVES INTERNATIONAL INC Logo
A formulator and custom contract manufacturer of nutritional supplements.
United States of America
NAII
Develops biotech products from endocrinology and herbal science for health markets.
South Korea
168330

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.